CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-27 | DECICCO CARL Chief Scientific Officer | Purchase | +5,500 | $16.00 | $88K | 258,397 |
| 2020-10-27 | Flagship Ventures Fund V General Partner LLC 10% owner | Purchase | +50,000 | $16.00 | $800K | 9,330,878 |
| 2020-10-27 | Flagship Ventures Fund V General Partner LLC 10% owner | Purchase | +50,000 | $16.00 | $800K | 1,491,441 |
| 2020-10-27 | Flagship Ventures Fund V General Partner LLC 10% owner | Purchase | +50,000 | $16.00 | $800K | 1,851,801 |
| 2020-10-27 | Abu Dhabi Investment Authority Former 10% Owner | Purchase | +150,000 | $16.00 | $2.4M | 1,231,081 |
Page 1 of 1 · 5 trades